5AM Ventures is a leading investment firm focused on funding and building next-generation life sciences companies
4:59 INITIATIVE
4:59 is 5AM’s hands-on internal effort to discover, incubate, and fund breakthrough science. We seek to partner alongside academics and entrepreneurs – often serving as an extension of the operating team – to establish proof-of-concept data that will enable a Series A Financing.
VENTURE CAPITAL
5AM Ventures Strategy primarily invests in private therapeutic companies. The funds are typically early-stage focused, with an emphasis on Series A companies.
PUBLIC EQUITY
5AM Opportunities Strategy invests in small and mid-cap public and later-stage private biotech and life science companies.
Supporting companies that are working to solve important healthcare needs via cutting-edge breakthroughs in medicine and science
Pushing the healthcare industry forward
-
$ 0 BCapital Raised Since InceptionData as of January 1, 2025We’re a life science venture capital firm founded in 2002 and currently investing $450M from 5AM Ventures VII and $300M from 5AM Opportunities II.
-
0PORTFOLIO COMPANIESOur focus is biopharmaceuticals, drug delivery technologies and life science instruments.
-
0ONGOING CLINICAL TRIALSHistorically, our portfolio companies have over 90,000 patients enrolled across 450+ test sites in clinical trials.
